|
|
|
MIRA INFORM REPORT
|
Report No. : |
489977 |
|
Report Date : |
06.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
SUBSTIPHARM DEVELOPPEMENT |
|
|
|
|
Registered Office : |
24 Rue Erlanger, 75016 Paris |
|
|
|
|
Country : |
France |
|
|
|
|
Financials (as on) : |
30.09.2012 |
|
|
|
|
Date of Incorporation : |
December 2004 |
|
|
|
|
Com. Reg. No.: |
RCS Paris B 480 064 385 |
|
|
|
|
Legal Form : |
Simplified Joint Stock Company |
|
|
|
|
Line of Business : |
Wholesale trade (B2B) of pharmaceutical products (4646Z) |
|
|
|
|
No. of Employees : |
20 to 49 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
C |
|
Credit Rating |
Explanation |
Rating Comments |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
France |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
FRANCE - ECONOMIC OVERVIEW
The French economy is diversified across all sectors. The government has
partially or fully privatized many large companies, including Air France,
France Telecom, Renault, and Thales. However, the government maintains a strong
presence in some sectors, particularly power, public transport, and defense
industries. France is the most visited country in the world with 83 million
foreign tourists in 2016, including 530,000 visitors for the 2016 Euro Cup.
France's leaders remain committed to a capitalism in which they maintain social
equity by means of laws, tax policies, and social spending that mitigate
economic inequality.
France's real GDP grew by 1.6% in 2017, up from 1.2% the year before.
The unemployment rate (including overseas territories) increased from 7.8% in
2008 to 10.2% in 2015, before falling to 9.5% in 2017. Youth unemployment in
metropolitan France decreased from 24.6% in the fourth quarter of 2014 to 24%
in the fourth quarter of 2016.
France’s public finances have historically been strained by high
spending and low growth. Despite measures to restore public finances, the
budget deficit rose from 3.3% of GDP in 2008 to 7.5% of GDP in 2009. In 2017,
the budget deficit improved to 2.9% of GDP, bringing it in compliance with the
EU-mandated 3% deficit target. Meanwhile, France's public debt rose from 89.5%
of GDP in 2012 to 96.9% in 2017.
Since entering office in May 2017, President Emmanuel MACRON launched a
series of economic reforms to improve competitiveness and boost economic
growth. President MACRON campaigned on reforming France’s labor code and in
late 2017 implemented a range of reforms to increase flexibility in the labor
market by making it easier for firms to hire and fire and simplifying
negotiations between employers and employees. In addition to labor reforms,
President MACRON’s proposed 2018 budget cuts public spending, taxes, and social
security contributions to spur private investment and increase purchasing
power.
|
Source
: CIA |
Company
summary
|
SIRET |
480 064 385 00028 |
||
|
Name |
SUBSTIPHARM DEVELOPPEMENT |
||
|
Acronym |
- |
||
|
Trade name |
- |
||
|
Status |
Economically active |
||
|
Postal Address |
SUBSTIPHARM
DEVELOPPEMENT |
||
|
Share Capital |
921,200 Euros |
||
|
Telephone |
01 43 18 13 00 |
||
|
Activity (APE) |
Wholesale trade (B2B) of pharmaceutical products (4646Z) |
RCS Registration |
RCS Paris B 480 064 385 |
|
Formation Date |
12/2004 |
EUR VAT Number |
FR23480064385 |
|
Deregistration Date |
- |
Last account Date |
30/09/2012 |
|
Court Registry Number |
20 0 4B23289 |
Incorporation Date |
12/2004 |
|
Registration Court |
Paris (75) |
Fax |
- |
|
Nationality |
France |
Legal form |
Simplified Joint Stock Company |
|
Currency |
Euros |
||
Key Financials
|
YEAR TO DATE |
TURNOVER |
GROSS OPERATING
SURPLUS |
SHAREHOLDER'S
EQUITY |
NET RESULT |
EMPLOYEES |
|
30/09/2012 |
32,331,040 € |
-2.48% Turnover |
8,145,197 € |
2,310,173 € |
20 to 49 employees |
|
30/09/2011 |
30,481,271 € |
2.84% Turnover |
7,038,224 € |
1,991,525 € |
20 to 49 employees |
|
30/09/2010 |
25,409,737 € |
-0.65% Turnover |
6,249,899 € |
1,746,462 € |
20 to 49 employees |
Directors
|
Current Directors |
3 |
Ultimate Holding Company
|
Name |
Company Number |
|
PACT PHARMA |
509667804 |
|
Affiliation links. |
|
Judgment and Preferential
|
Judgment |
No judgement |
|
|
|
Preferential Right |
No social security and tax office
preferential right to date |
||
Establishment Details
|
Type of Establishment |
Head Office |
Production Role |
- |
|
APE/NAF Code |
4646Z |
Activity |
Wholesale trade
(business-to-business) of pharmaceutical products |
|
Formation Date |
02/2013 |
Reason for Formation |
Formation |
|
Closure Date |
- |
Reason for Closure |
- |
|
Reactivation Date |
- |
Seasonality |
- |
|
Activity Nature |
- |
Activity Location |
- |
|
Trading Address |
24 RUE ERLANGER |
Department |
Paris (75) |
|
Location Surface |
- |
District |
1 |
|
City |
PARIS 16 |
Status |
Economically active |
|
Business Pages FT® |
LABORATOIRES PHARMACEUTIQUES |
Region |
Ile-de-France |
|
Area |
- |
||
|
Size of Urban Area |
Paris conglomeration |
Ultimate Parent(s)
2 ultimate parent company/companies for this
company
|
Company Name |
Activity (APE) |
APE/NAF Code |
City |
Post Code |
|
PACT PHARMA |
Activities of
holding companies |
6420Z |
PARIS 16 |
75016 |
|
SUBSTIPHARM DEVELOPPEMENT |
Wholesale
trade (business-to-business) of pharmaceutical products |
4646Z |
PARIS 16 |
75016 |
Other Establishment(s)
|
Regionality |
Legal unit with all establishments in same
area |
|
Mono-activity status |
Legal unit having all establishments with
the same main activity |
|
Branches |
1 branch entities in this company |
|
Company Name |
Company Type |
APE/NAF Code |
Activity |
City |
Post Code |
|
SUBSTIPHARM DEVELOPPEMENT |
Head Office |
4646Z |
Wholesale trade
(business-to-business) of pharmaceutical products |
PARIS 16 |
75016 |
|
SUBSTIPHARM DEVELOPPEMENT |
Branch |
4646Z |
Wholesale trade
(business-to-business) of pharmaceutical products |
PARIS 16 |
75016 |
Workforces
|
Workforce at address |
20 to 49 employees |
Company workforce |
20 to 49 employees |
|
|
|
Workforce account |
Workforce unknown |
|
|
|
30/09/2012 |
|
Commentary
The comments are ordered according to the
class of risk. Companies are compared with regard to other companies of the
same type. Thus a positive comment for one category can be negative for another
or can change depending on its value. This is a purely statistical decision.
|
The latest
account data is more than 5 years old, this has an impact on the rating.
Please contact Creditsafe with your latest financial statements if you want
the risk score to be recalculated |
|
The decrease of tangible
fixed assets over the last two accounting periods is 38 % |
|
The stock to
turnover ratio is 25.07 |
|
The creditor days
are 113.94 |
|
The sales to
current assets ratio is 1.78 |
|
The net turnover
is 32,331,040 € |
|
The liabilities
are 13,576,484 € |
|
The ratio total
assets to total liabilities is 1.59 |
|
The return on
total assets employed is 12.16 |
|
The risk
provisions are 330,922 € |
|
Industry code
with low risk rating |
|
The shareholder's
equity is 8,145,197 € |
|
The total assets are
22,144,859 € |
|
Department code
with low risk rating |
|
The pre-tax
profit is 2,693,344 € |
|
The decrease in
the gearing percentage over the last two accounting periods is 10 % |
|
The net current
assets are 18,209,161 € |
|
Low risk
workforce size |
|
The company has 3
directors |
Industry comparison
|
Activity (APE) |
Wholesale trade
(B2B) of pharmaceutical products (4646Z) |
Collective procedures
|
No judgment information for the company |
Preferential rights details and history
Summary of preferential rights
|
Company monitored since |
25/03/2009 |
||
|
Status of Monitoring |
No social security and tax office
preferential right to date |
||
Group Data
|
Ultimate parent company |
SUBSTIPHARM DEVELOPPEMENT |
|
|
Direct parent |
- |
|
|
Group – Number of companies |
3 |
|
|
Linkages – Number of companies |
||
|
Number of countries |
||
|
Parent |
PACT PHARMA |
|
|
Direct parent |
PACT PHARMA - 35 % |
|
|
Group – Number of companies |
3 |
|
|
Linkages – Number of companies |
||
|
Number of countries |
||
|
|
NAME |
SIREN |
PARTS |
LAST ACCOUNT
PUBLISHED |
|
1 |
SUBSTIPHARM DEVELOPPEMENT |
480064385 |
- |
30/09/2012 |
|
2 |
INOPHARM LTD |
- |
50 % |
- |
|
GENOVO DEVELOPMENT SERVICES LTD |
- |
50 % |
- |
Shareholders
Type of shareholders
Company: 35%Undefined: 65%CompanyUndefined
Shareholders
PACT PHARMA: 35%Undefined: 65%PACT
PHARMAUndefined
Linkages
|
No Linkages information available for the
company. |
Director(s)
|
Name |
M. BERTHIER LEOPOLD |
|||
|
Manager position |
President |
Date of birth |
02/10/1971 |
|
|
Place of birth |
PARIS |
|||
|
Type |
Individual |
Name at birth |
||
|
Name |
Mme. PRAUSE RAMATA |
|||
|
Manager position |
Managing director |
Date of birth |
18/02/1979 |
|
|
Place of birth |
PARIS |
|||
|
Type |
Individual |
Name at birth |
DIALLO |
|
Statutory Auditor
|
Name |
COGEED |
|||
|
Name of representative |
||||
|
Manager position |
Statutory auditor |
Date of birth |
- |
|
|
Place of birth |
||||
|
Type |
Moral person |
Name at birth |
||
Previous Directors
|
Manager position |
Title and name |
Date of Birth/Place of Birth |
|
|
President |
M. BERTHIER LEOPOLD |
02/10/1971 - PARIS (75008) |
|
|
Managing director |
Mme. HUSSENET-DOUGLAS GÉRALDINE |
21/06/1978 - SURESNES (92150) |
|
|
Managing director |
Mme. PRAUSE RAMATA |
18/02/1979 - PARIS (75014) |
Status history
|
No Status History |
Recent publications in Gazettes
|
Publication date |
Gazette Name |
Description |
|
|
09/08/2017 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1027 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions simplifiée. Administration
: Commissaire aux comptes suppléant partant : ALPHA REVISION. Capital
: 921200 EUR. Activité : . |
|||
|
20/07/2017 |
JAL |
Resignation / Revocation of the social
representative |
|
|
Les Petites affiches - La Loi - Le
Quotidien juridique - archives commerciales de la France
|
|||
|
25/03/2015 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 4749 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Capital : 921200 EUR. Activité : . |
|||
|
26/02/2015 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1352 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Administration : Directeur général et Pharmacien
responsable partant : Douglas, nom d'usage : Hussenet-Douglas, Géraldine,
nomination du Directeur général et Pharmacien responsable : Diallo, nom
d'usage : Prause, Ramata. Capital : 940000 EUR. Activité
: . |
|||
|
20/01/2015 |
JAL |
Appointment of the social representative |
|
|
Echos (Les) / Le Publicateur Légal - La Vie
Judiciaire
|
|||
|
20/01/2015 |
JAL |
Resignation / Revocation of the social
representative |
|
|
Echos (Les) / Le Publicateur Légal - La Vie
Judiciaire
|
|||
|
30/08/2013 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 9885 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Adresse : 24 rue Erlanger 75016 Paris. Commentaires
: Comptes annuels et rapports de l'exercice clos le : 30/09/2012. |
|||
|
10/03/2013 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1442 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Administration : Directeur général et Pharmacien
responsable partant : Arnaud, Agnès, nomination du Directeur général et
Pharmacien responsable : Douglas, nom d'usage : Hussenet-Douglas,
Géraldine. Capital : 940000 EUR. Activité : . Adresse
de l’établissement principal : 24 rue Erlanger, 75016 Paris. |
|||
|
15/02/2013 |
JAL |
Appointment of the social representative |
|
|
Gazette du palais (La)
|
|||
|
15/02/2013 |
JAL |
Resignation / Revocation of the social
representative |
|
|
Gazette du palais (La)
|
|||
|
15/02/2013 |
JAL |
Head Office Transfer |
|
|
Gazette du palais (La)
|
|||
|
05/09/2012 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 10201 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Adresse : 8 rue Bellini 75116 Paris. Commentaires
:Comptes annuels et rapports de l'exercice clos le : 30/09/2011. |
|||
|
20/09/2011 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 10649 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Adresse : 8 rue Bellini 75116 Paris. Commentaires
:Comptes annuels et rapports de l'exercice clos le : 30/09/2010. |
|||
|
06/09/2011 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1057 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Administration : Commissaire aux comptes titulaire
partant : BCJK SA, nomination du Commissaire aux comptes titulaire : COGEED,
Commissaire aux comptes suppléant partant : Koskas, David, nomination du
Commissaire aux comptes suppléant : ALPHA REVISION. Capital : 940000
EUR. Activité : . |
|||
|
27/09/2010 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 11505 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Adresse : 8 R BELLINI 75116 PARIS. Commentaires
:Comptes annuels et rapports de l'exercice clos le : 30/09/2009. |
|||
|
07/03/2010 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1191 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Administration : Directeur général partant :
Baby, nom d'usage : Armand, Claude, nomination du Directeur général et Pharmacien
responsable : Arnaud, Agnès, Pharmacien responsable partant : Baby, nom
d'usage : Armand, Claude. Capital : 940000 EUR. Activité
: L'acquisition, le développement et la vente de dossiers de
spécialités pharmaceutiques. L'exploitation sous toutes ses formes de
spécialités pharmaceutiques, y compris l'exportation, la fabrication,
l'importation, l'achat et la vente de tous produits incluant les médicaments
et dispositifs pharmaceutiques, médicaux, paramédicaux et vétérinaires, de
droguerie, d'hygiène, de soins, produits pour diagnostics et tests, produits
dentaires, cosmétiques, phytosanitaires et de parfumerie, de lutte contre la
pollution et d'écologie, ainsi que tous autres produits, articles, matières
et substances, de toutes natures et de tous usages, similaires, connexes ou
s'y rapportant achetés ou fabriqués en sous-Traitance, et de tous produits se
rattachant à la fabrication de ces produits et à leurs divers application,
l'utilisation de tous sous-produits et déchets provenant de ces fabrications.
L'étude, la recherche, la prise, l'acquisition sous toutes ses formes,
l'apport, le dépôt et l'exploitation de tous brevets, licences, marques et
procédés, l'acquisition, la concession, l'apport et l'exploitation de toutes
licences et inventions se rattachant à l'un des objets précités. Toutes
opérations commerciales se rattachant à des concessions ou à des
représentations générales qui peuvent lui être concédées. L'assistance et le
conseil auprès de sociétés dans les domaines précités. |
|||
|
12/02/2010 |
JAL |
Appointment of the social representative |
|
|
AFFICHES PARISIENNES ET DEPARTEMENTALES
|
|||
|
12/02/2010 |
JAL |
Resignation / Revocation of the social
representative |
|
|
AFFICHES PARISIENNES ET DEPARTEMENTALES
|
|||
|
13/11/2009 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 9714 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Adresse : 8 rue Bellini 75116 Paris. Commentaires
:Comptes annuels et rapports de l'exercice clos le : 30/09/2008. |
|||
|
17/06/2009 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 1785 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société par actions
simplifiée. Administration : modification du Président
Berthier, Leopold, Président du conseil de surveillance partant : Berthier,
Cesar, Membre du Directoire partant : Berthier, Bruno, Vice-Président et
Membre du conseil de surveillance partant : Berthier, Ophelie, Membre du
conseil de surveillance partant : Berthier, Amelie, modification du Directeur
général Baby, nom d'usage : Armand, Claude. Capital : 940000
EUR. Activité : L'acquisition, le développement et la vente de
dossiers de spécialités pharmaceutiques. L'exploitation sous toutes ses
formes de spécialités pharmaceutiques, y compris l'exportation, la
fabrication, l'importation, l'achat et la vente de tous produits incluant les
médicaments et dispositifs pharmaceutiques, médicaux, paramédicaux et
vétérinaires, de droguerie, d'hygiène, de soins, produits pour diagnostics et
tests, produits dentaires, cosmétiques, phytosanitaires et de parfumerie, de
lutte contre la pollution et d'écologie, ainsi que tous autres produits,
articles, matières et substances, de toutes natures et de tous usages,
similaires, connexes ou s'y rapportant achetés ou fabriqués en
sous-Traitance, et de tous produits se rattachant à la fabrication de ces
produits et à leurs divers application, l'utilisation de tous sous-produits
et déchets provenant de ces fabrications. L'étude, la recherche, la prise,
l'acquisition sous toutes ses formes, l'apport, le dépôt et l'exploitation de
tous brevets, licences, marques et procédés, l'acquisition, la concession,
l'apport et l'exploitation de toutes licences et inventions se rattachant à
l'un des objets précités. Toutes opérations commerciales se rattachant à des
concessions ou à des représentations générales qui peuvent lui être
concédées. L'assistance et le conseil auprès de sociétés dans les domaines
précités. |
|||
|
10/06/2009 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 2674 - 480 064 385 RCS Paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société anonyme à directoire et
conseil de surveillance. Administration : nomination du Pharmacien
responsable : Baby, nom d'usage : Armand, Claude. Capital : 940000
EUR. Activité : L'acquisition, le développement et la vente
de dossiers de spécialités pharmaceutiques. L'exploitation sous toutes ses
formes de spécialités pharmaceutiques, y compris l'exportation, la
fabrication, l'importation, l'achat et la vente de tous produits incluant les
médicaments et dispositifs pharmaceutiques, médicaux, paramédicaux et
vétérinaires, de droguerie, d'hygiène, de soins, produits pour diagnostics et
tests, produits dentaires, cosmétiques, phytosanitaires et de parfumerie, de
lutte contre la pollution et d'écologie, ainsi que tous autres produits,
articles, matières et substances, de toutes natures et de tous usages,
similaires, connexes ou s'y rapportant achetés ou fabriqués en
sous-Traitance, et de tous produits se rattachant à la fabrication de ces
produits et à leurs divers application, l'utilisation de tous sous-produits
et déchets provenant de ces fabrications. L'étude, la recherche, la prise,
l'acquisition sous toutes ses formes, l'apport, le dépôt et l'exploitation de
tous brevets, licences, marques et procédés, l'acquisition, la concession,
l'apport et l'exploitation de toutes licences et inventions se rattachant à
l'un des objets précités. Toutes opérations commerciales se rattachant à des
concessions ou à des représentations générales qui peuvent lui être
concédées. L'assistance et le conseil auprès de sociétés dans les domaines
précités. Adresse de l’établissement principal : 8 rue
Bellini, 75116 Paris. |
|||
|
11/03/2009 |
Bodacc C |
Comptes annuels et rapports |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 6824 - 480064385 RCS. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société anonyme à directoire et
conseil de surveillance. Adresse : 8 rue Bellini 75116
Paris. Commentaires : Comptes annuels et rapports de
l'exercice clos le : 30/09/2007. |
|||
|
21/07/2008 |
Bodacc B |
Modification et mutation diverse |
|
|
75 - PARIS GREFFE DU TRIBUNAL DE COMMERCE DE PARIS 3142 - 480 064 385 RCS paris. SUBSTIPHARM
DEVELOPPEMENT. Forme : Société anonyme à directoire et
conseil de surveillance. Administration : nomination du
Directeur général et Membre du Directoire : Baby, nom d'usage : Armand,
Claude. Capital : 940000 EUR. |
|||
|
06/12/2007 |
Bodacc C |
Avis de dépôt des comptes |
|
|
6342 - 480 064 385. RCS PARIS SUBSTIPHARM
DEVELOPPEMENT. Forme: Société anonyme à directoire et conseil de
surveillance. Adresse du siège social: 8 rue Bellini 75116 Paris. Comptes
annuels et rapports de l'exercice clos le: 30 septembre 2006. |
|||
|
16/01/2007 |
Bodacc C |
Avis de dépôt des comptes |
|
|
7995 - RCS Paris B 480 064 385. RC 04-B
23289. SUBSTIPHARM DEVELOPPEMENT. Forme: société anonyme à directoire et conseil
de surveillance. Adresse du siège social: 8, R Bellini,Paris, 75116 Paris.
Comptes annuels et rapports de l'exercice clos le: 31 décembre 2005. |
|||
|
11/06/2006 |
Bodacc B |
Modifications et mutations diverses |
|
|
1856 - RCS Paris B 480 064 385. RC 04-B
23289. SUBSTIPHARM DEVELOPPEMENT. Forme : S.A. à directoire et conseil de
surveillance. Capital : 940 000 euros. Adresse du siège social : 8 rue
Bellini,, 75116 Commentaires : modification survenue sur le capital (augmentation),
l'activité, l'administration et la date de début d'activité, suite à l'apport
scission par la STE SUBSTIPHARM S.A., RCS Paris B 402 086 300, 8 rue Bellini,
75116 Paris, de sa branche complète et autonome d'activité d'acquisition, de
développement et de vente de dossiers de spécialités pharmaceutiques.
Administration : modification d'un vice-président et membre du conseil de
surveillance : BERTHIER (Ophélie). Modification d'un membre du directoire :
BERTHIER (Bruno). Modification du président du directoire : BERTHIER
(Léopold). Nomination du président du conseil de surveillance : BERTHIER
(César). Etablissement principal - Activité : acquisition, développement et
vente de dossiers de spécialités pharmaceutiques achat, vente et
sous-traitance de tous produits et matières premières, de dispositifs
pharmaceutiques, médicaux et vétérinaires, de droguerie et de produits
d'hygiène, ainsi que de produits cosmétiques, phytosanitaires et de
parfumerie, de lutte contre la pollution et d'écologie. Etudes, recherche,
prise et acquisition sous toutes ses formes, ainsi que l'apport, le dépôt et
l'exploitation de toutes marques ou procédés. Acquisition, concession, apport
et exploitation de toutes licences et inventions se rattachant à l'un des
objets précités. Tout acte d'exploitation en relation avec l'une des
dispositions du Code général de la santé publique et ses annexes . Adresse :
8 rue Bellini, 75116 Date de début d'activité : 31 décembre 2005. |
|||
|
25/01/2005 |
Bodacc A |
Création d'établissement |
|
|
1352 - RCS Paris B 480 064 385. RC 04-B
23289. SUBSTIPHARM DEVELOPPEMENT. Forme : S.A. à directoire et conseil de
surveillance. Capital : 40 000 euros. Adresse du siège social : 8 rue
Bellini, 75116 Paris. Administration : directeur général unique : BERTHIER
(Léopold). Président du conseil de surveillance : BERTHIER (Ophélie).
Vice-président et membre du conseil de surveillance : BERTHIER (Bruno).
Membre du conseil de surveillance : BERTHIER (Amélie). Commissaire aux
comptes titulaire : BCJK S.A. Commissaire aux comptes suppléant : KOSKAS
(David). Cette société se constitue , mais n'exploite provisoirement aucun
établissement. |
|||
Company events history
|
Date |
Description |
|
09/08/2017 |
Bodacc B: Various editing or changing |
|
28/07/2017 |
Amendment |
|
28/07/2017 |
New auditor |
|
20/07/2017 |
Legal Gazette: Resignation / Revocation of
the social representative |
|
25/03/2015 |
Bodacc B: Various editing or changing |
|
10/03/2015 |
Capital increase |
|
10/03/2015 |
Updated articles of association |
|
10/03/2015 |
Power of attorney |
|
10/03/2015 |
Capital reduction |
|
10/03/2015 |
Amendment |
|
26/02/2015 |
Bodacc B: Various editing or changing |
|
11/02/2015 |
Minutes of general meeting of shareholders |
|
11/02/2015 |
Appointment/resignation of company officers |
|
20/01/2015 |
Legal Gazette: Resignation / Revocation of
the social representative |
|
18/12/2014 |
Legal Gazette: Appointment of the social
representative |
|
02/12/2014 |
Capital reduction |
|
02/12/2014 |
Minutes of general meeting of shareholders |
|
04/10/2013 |
New subsidiarie(s) detected |
|
04/10/2013 |
New ultimate parent |
|
04/10/2013 |
New parent detected |
|
30/08/2013 |
Bodacc C : Deposit accounts notice |
|
28/07/2013 |
Update Limit |
|
28/07/2013 |
Consideration of a balance sheet that has
led to a reassessment of this company's creditworthiness |
|
10/03/2013 |
Bodacc B: Various editing or changing |
|
22/02/2013 |
Registered office transferred inside
jurisdiction of the Commercial Court |
|
22/02/2013 |
Minutes of general meeting of shareholders |
|
22/02/2013 |
Appointment/resignation of company officers |
|
22/02/2013 |
Updated articles of association |
|
22/02/2013 |
Amendment |
|
15/02/2013 |
Transfer of Establishment |
|
15/02/2013 |
Legal Gazette: Resignation / Revocation of
the social representative |
|
15/02/2013 |
Legal Gazette: Head Office Transfer |
|
15/02/2013 |
Update of Company Head Office Identifier |
|
21/12/2012 |
Legal Gazette: Appointment of the social
representative |
|
16/11/2012 |
Consideration of a balance sheet that has
led to a reassessment of this company's creditworthiness |
|
30/09/2012 |
New accounts available |
|
05/09/2012 |
Bodacc C : Deposit accounts notice |
|
30/09/2011 |
New accounts available |
|
20/09/2011 |
Bodacc C : Deposit accounts notice |
|
06/09/2011 |
Bodacc B: Various editing or changing |
|
01/09/2011 |
Consideration of a balance sheet that has
led to a reassessment of this company's creditworthiness |
|
22/08/2011 |
Amendment |
|
22/08/2011 |
New auditor |
|
30/09/2010 |
New accounts available |
|
27/09/2010 |
Bodacc C : Deposit accounts notice |
|
07/03/2010 |
Bodacc B: Various editing or changing |
|
17/02/2010 |
Changes to the Board of Directors |
|
17/02/2010 |
Appointment/resignation of company officers |
|
17/02/2010 |
Minutes of general meeting of shareholders |
|
12/02/2010 |
Legal Gazette: Resignation / Revocation of
the social representative |
|
31/12/2009 |
Legal Gazette: Appointment of the social representative |
|
13/11/2009 |
Bodacc C : Deposit accounts notice |
|
30/09/2009 |
New accounts available |
|
17/06/2009 |
Bodacc B: Various editing or changing |
|
10/06/2009 |
Bodacc B: Various editing or changing |
|
02/06/2009 |
Changes to the Board of Directors |
|
02/06/2009 |
Appointment/resignation of company officers |
|
02/06/2009 |
Minutes of general meeting of shareholders |
|
02/06/2009 |
New legal form – new category |
|
02/06/2009 |
Private document |
|
02/06/2009 |
Updated articles of association |
|
02/06/2009 |
Updated articles of association |
|
02/06/2009 |
Minutes of general meeting of shareholders |
|
26/05/2009 |
Updated articles of association |
|
26/05/2009 |
Private document |
|
26/05/2009 |
Minutes of general meeting of shareholders |
|
26/05/2009 |
Minutes of general meeting of shareholders |
|
26/05/2009 |
Correction of a material error |
|
26/05/2009 |
Change to corporate purpose |
|
26/05/2009 |
Change to corporate purpose |
|
26/05/2009 |
Appointment/resignation of company officers |
|
26/05/2009 |
Appointment/resignation of company officers |
|
26/05/2009 |
Amendment |
|
26/05/2009 |
Updated articles of association |
|
25/03/2009 |
Collection of preferential rights activated
for this company |
|
11/03/2009 |
Bodacc C : Deposit accounts notice |
|
30/09/2008 |
New accounts available |
|
21/07/2008 |
New Bodacc B ads detected |
|
21/07/2008 |
Bodacc B: Various editing or changing |
|
20/05/2008 |
Changes to the Board of Directors |
|
20/05/2008 |
Private document |
|
20/05/2008 |
Appointment/resignation of company officers |
|
20/05/2008 |
Appointment/resignation of company officers |
|
20/05/2008 |
Amendment |
|
20/05/2008 |
Minutes of general meeting of shareholders |
|
30/09/2007 |
New accounts available |
|
30/09/2006 |
New accounts available |
|
07/02/2006 |
Appointment/resignation of company officers |
|
07/02/2006 |
Capital increase |
|
07/02/2006 |
Declaration of conformity |
|
07/02/2006 |
Minutes of Board meeting |
|
07/02/2006 |
New chairman (CEO, CoB) |
|
07/02/2006 |
Partial contribution |
|
07/02/2006 |
Private document |
|
07/02/2006 |
Updated articles of association |
|
07/02/2006 |
Amendment |
|
07/02/2006 |
Minutes of general meeting of shareholders |
|
31/12/2005 |
New accounts available |
|
21/12/2005 |
Private document |
|
21/12/2005 |
Audit or Management Report |
|
30/11/2005 |
Planned merger |
|
30/11/2005 |
Spin-off |
|
30/11/2005 |
Private document |
|
29/09/2005 |
Minutes of general meeting of shareholders |
|
29/09/2005 |
Extension of term |
|
29/09/2005 |
New closing date |
|
29/09/2005 |
Updated articles of association |
|
29/09/2005 |
Private document |
|
28/12/2004 |
Amendment |
|
28/12/2004 |
Appointment/resignation of company officers |
|
28/12/2004 |
Articles of association |
|
28/12/2004 |
Private document |
|
28/12/2004 |
Fund deposit certificate |
|
28/12/2004 |
Minutes of general meeting of shareholders |
|
28/12/2004 |
New chairman (CEO, CoB) |
|
28/12/2004 |
Company formation |
Establishment events history
|
Date |
Description |
|
09/05/2017 |
Update of phone numbers |
|
14/01/2015 |
Modification of Head office |
|
15/02/2013 |
Formation of Head office (after transfer) |
Synthesized Accounts
Annual Accounts
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Account period (month) |
12 |
12 |
12 |
|
Account Type |
Normal |
Normal |
Normal |
|
Date of capture |
26/07/2013 |
14/11/2012 |
31/08/2011 |
|
Activity Code |
4646Z |
4646Z |
4646Z |
|
Employees |
0 |
0 |
0 |
Active account
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Capital not called |
0 |
0% |
0 |
0% |
0 |
0 |
0% |
|
Total fixed assets |
3,934,614 |
12.0% |
3,513,422 |
38.5% |
2,537,460 |
32,106 |
12155.3% |
|
Intangible assets |
218 |
-91.3% |
2,493 |
-95.6% |
57,257 |
130 |
67.7% |
|
Tangible assets |
130,506 |
-37.6% |
209,157 |
0.6% |
207,971 |
11,428 |
1042.0% |
|
Financial assets |
3,803,890 |
15.2% |
3,301,772 |
45.3% |
2,272,232 |
2,289 |
166117.6% |
|
Net current assets |
18,209,161 |
36.8% |
13,309,989 |
-10.9% |
14,946,258 |
378,866 |
4706.2% |
|
Stocks |
8,104,817 |
28.4% |
6,310,423 |
-7.8% |
6,847,143 |
41,753 |
19311.3% |
|
Advanced payments |
6,836 |
-65.8% |
19,977 |
-16.5% |
23,926 |
0 |
0% |
|
Receivables |
8,494,176 |
55.0% |
5,480,423 |
-24.4% |
7,246,861 |
177,653 |
4681.3% |
|
Securities and cash |
1,603,332 |
6.9% |
1,499,166 |
81.0% |
828,328 |
58,295 |
2650.4% |
|
Prepaid expenses |
- |
- |
- |
- |
- |
12 |
- |
|
Accounts of regularization |
1,085 |
-95.9% |
26,289 |
115.7% |
12,190 |
0 |
0% |
|
Total Assets |
22,144,859 |
31.4% |
16,849,700 |
-3.7% |
17,495,908 |
474,162 |
4570.3% |
Passive Account
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Shareholders' equity |
8,145,197 |
15.7% |
7,038,224 |
12.6% |
6,249,899 |
134,495 |
5956.1% |
|
Share capital |
940,000 |
0% |
940,000 |
0% |
940,000 |
30,000 |
3033.3% |
|
Other capital resources |
0 |
0% |
0 |
0% |
0 |
0 |
0% |
|
Risk Provisions |
330,922 |
-32.8% |
492,539 |
3940.2% |
12,191 |
0 |
0% |
|
Liabilities |
13,576,484 |
45.8% |
9,310,071 |
-16.8% |
11,196,262 |
275,157 |
4834.1% |
|
Financial liabilities |
2,151,421 |
13.5% |
1,895,891 |
-10.3% |
2,112,775 |
20,491 |
10399.6% |
|
Advanced payments received |
0 |
0% |
0 |
0% |
0 |
0 |
0% |
|
Trade account payables |
10,092,865 |
90.6% |
5,294,008 |
-31.4% |
7,720,170 |
100,535 |
9939.2% |
|
Tax and social liabilities |
685,389 |
-19.5% |
851,215 |
36.2% |
625,183 |
69,832 |
881.5% |
|
Other debts and fixed assets
liabilities |
110,739 |
-78.8% |
522,269 |
81.8% |
287,306 |
6,678 |
1558.4% |
|
Account regularization |
628,327 |
-16.8% |
755,554 |
54.7% |
488,384 |
0 |
0% |
|
Total liabilities |
22,144,859 |
31.4% |
16,849,700 |
-3.7% |
17,495,908 |
474,162 |
4570.3% |
Results
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Sales of Goods |
36,316,876 |
6.8% |
34,018,258 |
26.8% |
26,819,810 |
743,534 |
4784.4% |
|
Net turnover |
32,331,040 |
6.1% |
30,481,271 |
20.0% |
25,409,737 |
730,649 |
4325.0% |
|
of which net export turnover |
2,192,408 |
23.5% |
1,774,662 |
-30.7% |
2,559,699 |
0 |
0% |
|
Operating charges |
33,419,078 |
8.8% |
30,729,611 |
24.8% |
24,624,277 |
720,652 |
4537.3% |
|
Operating profit/loss |
2,897,798 |
-11.9% |
3,288,647 |
49.8% |
2,195,533 |
20,151 |
14280.8% |
|
Financial income |
158,172 |
15.1% |
137,467 |
66.3% |
82,670 |
168 |
94050.0% |
|
Financial charges |
164,241 |
0.6% |
163,291 |
-37.6% |
261,728 |
1,312 |
12423.1% |
|
Financial profit/loss |
-6,069 |
76.5% |
-25,824 |
85.6% |
-179,058 |
-182 |
-3243.8% |
|
Pretax net operating income |
2,891,729 |
-11.4% |
3,262,823 |
61.8% |
2,016,475 |
19,118 |
15026.1% |
|
Extraordinary income |
201,174 |
728.6% |
24,278 |
-44.5% |
43,749 |
38 |
529305.3% |
|
Extraordinary charges |
399,562 |
-43.7% |
709,942 |
266.6% |
193,650 |
358 |
111509.5% |
|
Extraordinary profit/loss |
-198,388 |
71.1% |
-685,664 |
-357.4% |
-149,901 |
0 |
0% |
|
Net result |
2,310,173 |
16.0% |
1,991,525 |
14.0% |
1,746,462 |
16,785 |
13663.7% |
Accounts - Active
Normal Account
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Months |
12 |
12 |
12 |
Grand Total - Active Accounts (I to VI)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Grand Total (I to VI) |
Net |
22,144,859 |
31.4% |
16,849,700 |
-3.7% |
17,495,908 |
|
Gross |
CO |
23,481,782 |
23.2% |
19,062,664 |
-4.4% |
19,937,472 |
|
Amortisation |
1A |
1,336,923 |
-39.6% |
2,212,964 |
-9.4% |
2,441,564 |
Non declared distributed capital (I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Non declared distributed capital (I) |
AA3 |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AA |
0 |
0% |
0 |
0% |
0 |
Active fixed asset (II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total Active fixed asset (II) |
Net |
3,934,614 |
12.0% |
3,513,422 |
38.5% |
2,537,460 |
|
Gross |
BJ |
5,030,458 |
10.1% |
4,568,431 |
30.1% |
3,510,674 |
|
Amortisation |
BK |
1,095,844 |
3.9% |
1,055,009 |
8.4% |
973,214 |
Intangible fixed assets
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Start-up cost |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AB |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AC |
0 |
0% |
0 |
0% |
0 |
|
R&D expenses |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
CX |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
CQ |
0 |
0% |
0 |
0% |
0 |
|
Distributorships, patents |
Net |
218 |
-91.3% |
2,493 |
-95.6% |
57,257 |
|
Gross |
AF |
348,211 |
0.3% |
347,111 |
-9.8% |
384,684 |
|
Amortisation |
AG |
347,993 |
1.0% |
344,618 |
5.3% |
327,427 |
|
Goodwill |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AH |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AI |
0 |
0% |
0 |
0% |
0 |
|
Other intangible fixed assets |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AJ |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AK |
0 |
0% |
0 |
0% |
0 |
|
Pre-payments and downpayments |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AL |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AM |
0 |
0% |
0 |
0% |
0 |
|
Sub Total Intangible asset |
Net |
218 |
-91.3% |
2,493 |
-95.6% |
57,257 |
Tangible fixed assets
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Lands |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AN |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AO |
0 |
0% |
0 |
0% |
0 |
|
Buildings |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AP |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AQ |
0 |
0% |
0 |
0% |
0 |
|
Plant |
Net |
75,139 |
-18.1% |
91,705 |
45.6% |
62,979 |
|
Gross |
AR |
114,327 |
5.8% |
108,071 |
49.8% |
72,166 |
|
Amortisation |
AS |
39,188 |
139.4% |
16,366 |
78.1% |
9,187 |
|
Other tangible fixed assets |
Net |
55,367 |
-40.4% |
92,929 |
-31.8% |
136,207 |
|
Gross |
AT |
369,041 |
-7.9% |
400,634 |
2.7% |
390,209 |
|
Amortisation |
AU |
313,674 |
1.9% |
307,705 |
21.1% |
254,002 |
|
Fixed assets in construction |
Net |
0 |
0% |
24,523 |
179.1% |
8,785 |
|
Gross |
AV |
0 |
0% |
24,523 |
75.7% |
13,954 |
|
Amortisation |
AW |
0 |
0% |
0 |
0% |
5,169 |
|
Advances and payments on account |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
AX |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
AY |
0 |
0% |
0 |
0% |
0 |
|
Sub Total Tangible asset |
Net |
130,506 |
-37.6% |
209,157 |
0.6% |
207,971 |
Financial assets
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Associates at equity |
Net |
0 |
0% |
1,420,833 |
0% |
0 |
|
Gross |
CS |
0 |
0% |
1,570,300 |
0% |
0 |
|
Amortisation |
CT |
0 |
0% |
149,467 |
0% |
0 |
|
Other participations |
Net |
1,420,833 |
0% |
0 |
0% |
1,420,833 |
|
Gross |
CU |
1,570,300 |
563.0% |
236,853 |
-84.9% |
1,570,300 |
|
Amortisation |
CV |
149,467 |
-36.9% |
236,853 |
58.5% |
149,467 |
|
Inter-company receivables |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
BB |
245,522 |
0% |
0 |
0% |
227,962 |
|
Amortisation |
BC |
245,522 |
0% |
0 |
0% |
227,962 |
|
Other investment securities |
Net |
31,800 |
112.0% |
15,000 |
0% |
15,000 |
|
Gross |
BD |
31,800 |
112.0% |
15,000 |
0% |
15,000 |
|
Amortisation |
BE |
0 |
0% |
0 |
0% |
0 |
|
Loans |
Net |
2,304,335 |
26.6% |
1,819,697 |
130.3% |
790,157 |
|
Gross |
BF |
2,304,335 |
26.6% |
1,819,697 |
130.3% |
790,157 |
|
Amortisation |
BG |
0 |
0% |
0 |
0% |
0 |
|
Other financial assets |
Net |
46,922 |
1.5% |
46,242 |
0% |
46,242 |
|
Gross |
BH |
46,922 |
1.5% |
46,242 |
0% |
46,242 |
|
Amortisation |
BI |
0 |
0% |
0 |
0% |
0 |
|
Sub Total Financial assets |
Net |
3,803,890 |
15.2% |
3,301,772 |
45.3% |
2,272,232 |
Current Assets (III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total Current Assets |
Net |
18,209,161 |
36.8% |
13,309,989 |
-10.9% |
14,946,258 |
|
Gross |
CJ |
18,450,240 |
27.5% |
14,467,943 |
-11.9% |
16,414,608 |
|
Amortisation |
CK |
241,079 |
-79.2% |
1,157,954 |
-21.1% |
1,468,350 |
Stocks
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Raw materials |
Net |
4,904,403 |
28.9% |
3,803,457 |
-30.0% |
5,432,308 |
|
Gross |
BL |
5,017,095 |
18.6% |
4,231,093 |
-22.3% |
5,446,416 |
|
Amortisation |
BM |
112,692 |
-73.6% |
427,636 |
2931.2% |
14,108 |
|
Work in progress (goods) |
Net |
0 |
0% |
2,506,966 |
0% |
0 |
|
Gross |
BN |
0 |
0% |
3,237,284 |
0% |
0 |
|
Amortisation |
BO |
0 |
0% |
730,318 |
0% |
0 |
|
Work in progress (services) |
Net |
3,160,639 |
0% |
0 |
0% |
1,414,835 |
|
Gross |
BP |
3,289,026 |
0% |
0 |
0% |
2,869,077 |
|
Amortisation |
BQ |
128,387 |
0% |
0 |
0% |
1,454,242 |
|
Semi-finished and finished products |
Net |
39,775 |
0% |
0 |
0% |
0 |
|
Gross |
BR |
39,775 |
0% |
0 |
0% |
0 |
|
Amortisation |
BS |
0 |
0% |
0 |
0% |
0 |
|
Goods for resale |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
BT |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
BU |
0 |
0% |
0 |
0% |
0 |
|
Sub Total Stocks |
Net |
8,104,817 |
28.4% |
6,310,423 |
-7.8% |
6,847,143 |
Advance payments to suppliers
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Advance payments to suppliers |
Net |
6,836 |
-65.8% |
19,977 |
-16.5% |
23,926 |
|
Gross |
BV |
6,836 |
-65.8% |
19,977 |
-16.5% |
23,926 |
|
Amortisation |
BW |
0 |
0% |
0 |
0% |
0 |
Debtors
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Trade accounts receivable |
Net |
6,210,077 |
55.2% |
4,000,546 |
-31.8% |
5,867,987 |
|
Gross |
BX |
6,210,077 |
55.2% |
4,000,546 |
-31.8% |
5,867,987 |
|
Amortisation |
BY |
0 |
0% |
0 |
0% |
0 |
|
Other debtors |
Net |
2,069,520 |
60.9% |
1,286,417 |
43.4% |
896,864 |
|
Gross |
BZ |
2,069,520 |
60.9% |
1,286,417 |
43.4% |
896,864 |
|
Amortisation |
CA |
0 |
0% |
0 |
0% |
0 |
|
Capital subscribed and called up |
Net |
0 |
0% |
0 |
0% |
0 |
|
Gross |
CB |
0 |
0% |
0 |
0% |
0 |
|
Amortisation |
CC |
0 |
0% |
0 |
0% |
0 |
|
Sub Total debtors |
Net |
8,279,597 |
56.6% |
5,286,963 |
-21.8% |
6,764,851 |
Divers
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Investment securities |
Net |
0 |
0% |
56,741 |
-79.7% |
279,468 |
|
Gross |
CD |
0 |
0% |
56,741 |
-79.7% |
279,468 |
|
Amortisation |
CE |
0 |
0% |
0 |
0% |
0 |
|
Cash and cash equivalents |
Net |
1,603,332 |
11.2% |
1,442,425 |
162.8% |
548,860 |
|
Gross |
CF |
1,603,332 |
11.2% |
1,442,425 |
162.8% |
548,860 |
|
Amortisation |
CG |
0 |
0% |
0 |
0% |
0 |
|
Sub Total Divers |
Net |
1,603,332 |
6.9% |
1,499,166 |
81.0% |
828,328 |
Prepaid expenses
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Prepaid expenses |
Net |
214,579 |
10.9% |
193,460 |
-59.9% |
482,010 |
|
Gross |
CH |
214,579 |
10.9% |
193,460 |
-59.9% |
482,010 |
|
Amortisation |
CI |
0 |
0% |
0 |
0% |
0 |
Equalization accounts (IV to VI)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Expenses of loan issue to be spread |
CW3 |
0 |
0% |
0 |
0% |
0 |
|
Gross |
0 |
0% |
0 |
0% |
0 |
|
|
Premiums on redemption of bonds |
CM3 |
0 |
0% |
0 |
0% |
0 |
|
Gross |
0 |
0% |
0 |
0% |
0 |
|
|
Currency differential gain |
CN3 |
1,085 |
-95.9% |
26,289 |
115.7% |
12,190 |
|
Gross |
1,085 |
-95.9% |
26,289 |
115.7% |
12,190 |
References
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Due within one year |
CP |
0 |
0% |
0 |
0% |
0 |
|
Due after one year |
CR |
0 |
0% |
0 |
0% |
0 |
Accounts - Passive
Grand Total - Passive Accounts (I to V)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Grand Total (I to V) |
EE |
22,144,859 |
31.4% |
16,849,700 |
-3.7% |
17,495,908 |
Shareholder Equity (I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total shareholders' equity (Total I) |
DL |
8,145,197 |
15.7% |
7,038,224 |
12.6% |
6,249,899 |
|
Equity and shareholders' equity |
DA |
940,000 |
0% |
940,000 |
0% |
940,000 |
|
Issue and merger premiums |
DB |
1,192 |
0% |
1,192 |
0% |
1,192 |
|
Revaluation differentials |
DC |
0 |
0% |
0 |
0% |
0 |
|
Of which equity differential |
EK |
0 |
0% |
0 |
0% |
0 |
|
Legal reserve |
DD |
94,000 |
0% |
94,000 |
0% |
94,000 |
|
Statutory or contractual reserve |
DE |
0 |
0% |
0 |
0% |
0 |
|
Special regulated reserves |
DF |
0 |
0% |
0 |
0% |
0 |
|
Of which special reserve of provisions for
current fluctuation |
B1 |
0 |
0% |
0 |
0% |
0 |
|
Other reserves |
DG |
0 |
0% |
0 |
0% |
0 |
|
Of which reserve for buying originals works
from alive artists |
EJ |
0 |
0% |
0 |
0% |
0 |
|
Profits or losses brought forward |
DH |
4,799,832 |
19.7% |
4,011,507 |
15.7% |
3,468,245 |
|
Profit or loss for the period |
DI |
2,310,173 |
16.0% |
1,991,525 |
14.0% |
1,746,462 |
|
Investment grants |
DJ |
0 |
0% |
0 |
0% |
0 |
|
Special tax-allowable reserves |
DK |
0 |
0% |
0 |
0% |
0 |
Other capital resources (II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total other capital resources (Total II) |
DO |
0 |
0% |
0 |
0% |
0 |
|
Income from participating securities |
DM |
0 |
0% |
0 |
0% |
0 |
|
Conditional loans |
DN |
0 |
0% |
0 |
0% |
0 |
Provisions for risks and charges (III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total provisions for risks and charges
(Total III) |
DR |
330,922 |
-32.8% |
492,539 |
3940.2% |
12,191 |
|
Risk provisions |
DP |
95,861 |
-20.8% |
121,064 |
893.1% |
12,191 |
|
Reserves for charges |
DQ |
235,061 |
-36.7% |
371,475 |
0% |
0 |
Liabilities (IV)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total Liabilities (Total IV) |
EC |
13,576,484 |
45.8% |
9,310,071 |
-16.8% |
11,196,262 |
|
Convertible debentures |
DS |
0 |
0% |
0 |
0% |
0 |
|
Other debentures |
DT |
0 |
0% |
0 |
0% |
0 |
|
Bank loans and liabilities |
DU |
2,593 |
18.3% |
2,192 |
-28.1% |
3,050 |
|
Sundry loans and financial liabilities |
DV |
2,148,828 |
13.5% |
1,893,699 |
-10.2% |
2,109,725 |
|
Of which participating loans |
EI |
0 |
0% |
0 |
0% |
0 |
|
Advance payments received for current
orders |
DW |
0 |
0% |
0 |
0% |
0 |
|
Trade accounts payables |
DX |
10,092,865 |
90.6% |
5,294,008 |
-31.4% |
7,720,170 |
|
Tax and social security liabilities |
DY |
685,389 |
-19.5% |
851,215 |
36.2% |
625,183 |
|
Fixed asset liabilities |
DZ |
0 |
0% |
0 |
0% |
0 |
|
Other debts |
EA |
18,482 |
-96.4% |
513,403 |
105.6% |
249,749 |
Translation loss (V)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Translation loss (Total V) |
ED |
92,257 |
940.6% |
8,866 |
-76.4% |
37,557 |
Equalization accounts
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Deferred income |
EB |
628,327 |
-16.8% |
755,554 |
54.7% |
488,384 |
References
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Of which tax-allowable reserve |
EF |
0 |
0% |
0 |
0% |
0 |
|
Deferred income and liabilities |
EG |
0 |
0% |
8,769,461 |
-21.7% |
11,196,262 |
|
Of which current bank facilities |
EH |
0 |
0% |
0 |
0% |
0 |
Result account
1 - Operating result (I-II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Operating result (Total I-II) |
GG |
2,897,798 |
-11.9% |
3,288,647 |
49.8% |
2,195,533 |
2 - Financial result (V-VI)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Financial result (Total V-VI) |
GV |
-6,069 |
76.5% |
-25,824 |
85.6% |
-179,058 |
3 - Pre-tax net operating income result (I to
VI)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Pre-tax net operating income (Total
I-II+II-IV+V-VI) |
GW |
2,891,729 |
-11.4% |
3,262,823 |
61.8% |
2,016,475 |
4 - Extraordinary result (VII-VIII)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
|||
|
Extraordinary result (Total VII-VIII) |
HI |
-198,388 |
71.1% |
-685,664 |
-357.4% |
-149,901 |
Profit or loss
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Profit or loss |
HN |
2,310,173 |
16.0% |
1,991,525 |
14.0% |
1,746,462 |
Total Income (I+III+V+VII)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total Income (Total I+III+V+VII) |
HL |
36,676,222 |
7.3% |
34,180,003 |
26.8% |
26,946,229 |
Total Charges (Total II+IV+VI+VIII+IX+X)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total Charges (Total II+IV+VI+VIII+IX+X) |
HM |
34,366,052 |
6.8% |
32,188,477 |
27.7% |
25,199,767 |
Operating income (I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total operating income (Total I) |
FR |
36,316,876 |
6.8% |
34,018,258 |
26.8% |
26,819,810 |
Operating income (details)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Sale of goods for resale |
FC |
653,387 |
231.5% |
197,083 |
0% |
0 |
|
France |
FA |
78,401 |
-38.2% |
126,913 |
0% |
0 |
|
Export |
FB |
574,986 |
719.4% |
70,170 |
0% |
0 |
|
Sale of goods produced |
FF |
29,604,707 |
4.4% |
28,359,502 |
35.2% |
20,981,454 |
|
France |
FD |
28,421,172 |
5.4% |
26,971,068 |
41.2% |
19,105,409 |
|
Export |
FE |
1,183,535 |
-14.8% |
1,388,434 |
-26.0% |
1,876,045 |
|
Sale of services |
FI |
2,072,946 |
7.7% |
1,924,686 |
-56.5% |
4,428,283 |
|
France |
FG |
1,639,059 |
1.9% |
1,608,628 |
-57.0% |
3,744,629 |
|
Export |
FH |
433,887 |
37.3% |
316,058 |
-53.8% |
683,654 |
|
Net turnover |
FL |
32,331,040 |
6.1% |
30,481,271 |
20.0% |
25,409,737 |
|
France |
FJ |
30,138,632 |
5.0% |
28,706,609 |
25.6% |
22,850,038 |
|
Export |
FK |
2,192,408 |
23.5% |
1,774,662 |
-30.7% |
2,559,699 |
|
Stocked production |
FM |
91,517 |
-74.6% |
360,077 |
122.3% |
-1,617,659 |
|
Self-constructed assets |
FN |
0 |
0% |
0 |
0% |
0 |
|
Operating grants |
FO |
0 |
0% |
0 |
0% |
0 |
|
Release of reserves and provisions |
FP |
1,195,056 |
24.0% |
963,683 |
56.3% |
616,367 |
|
Other income |
FQ |
2,699,263 |
22.0% |
2,213,227 |
-8.2% |
2,411,365 |
Operating charges (II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total operating charges (Total II) |
GF |
33,419,078 |
8.8% |
30,729,611 |
24.8% |
24,624,277 |
Exploitation charges
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Purchase of goods for resale |
FS |
529,424 |
313.1% |
128,169 |
0% |
0 |
|
Change in stocks of goods for resale |
FT |
0 |
0% |
0 |
0% |
0 |
|
Purchase of raw materials |
FU |
12,786,967 |
31.8% |
9,704,018 |
-11.8% |
11,008,035 |
|
Change in stocks of raw materials |
FV |
-786,002 |
-164.7% |
1,215,323 |
162.7% |
-1,936,860 |
|
Other external purchases and charges |
FW |
18,741,654 |
9.8% |
17,076,676 |
31.5% |
12,990,678 |
|
Tax, duty and similar payments |
FX |
180,388 |
8.8% |
165,805 |
-14.8% |
194,626 |
|
Payroll |
FY |
1,199,119 |
2.9% |
1,165,240 |
0.0% |
1,165,623 |
|
Social security costs |
FZ |
572,492 |
10.3% |
519,120 |
-2.8% |
534,168 |
Depreciation
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Depreciation of fixed assets |
GA |
132,228 |
-0.1% |
132,368 |
-4.8% |
138,989 |
|
Amortisation of fixed assets |
GB |
0 |
0% |
163 |
-99.9% |
207,148 |
|
Depreciation/amortisation of current assets |
GC |
60,680 |
-90.3% |
622,398 |
93.4% |
321,824 |
|
Provisions for risks and charges |
GD |
0 |
0% |
0 |
0% |
0 |
Other charges
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Other charges |
GE |
2,128 |
542.9% |
331 |
619.6% |
46 |
Operating charges (III-IV)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Share of joint-venture transferred to other
partner(s) (Total III) |
GH |
0 |
0% |
0 |
0% |
0 |
|
Share of joint venture transferred from
other partner(s) (Total IV) |
GI |
0 |
0% |
0 |
0% |
0 |
Financial income (V)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total financial income (Total V) |
GP |
158,172 |
15.1% |
137,467 |
66.3% |
82,670 |
|
Share financial income |
GJ |
0 |
0% |
0 |
0% |
0 |
|
Other investment income & capitalised
receivables |
GK |
95,804 |
52.1% |
62,983 |
146.1% |
25,595 |
|
Other interest and similar income |
GL |
1,749 |
0% |
0 |
0% |
0 |
|
Released provisions and transferred charges |
GM |
26,288 |
115.7% |
12,190 |
0% |
0 |
|
Exchange gains |
GN |
33,718 |
-43.1% |
59,209 |
14.4% |
51,750 |
|
Net income from disposal of investment
securities |
GO |
613 |
-80.1% |
3,085 |
-42.1% |
5,325 |
Financial charge (VI)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total financial charge (Total VI) |
GU |
164,241 |
0.6% |
163,291 |
-37.6% |
261,728 |
|
Financial reserves and provisions |
GQ |
1,085 |
-95.9% |
26,288 |
115.6% |
12,191 |
|
Interest and similar charges |
GR |
86,160 |
13.7% |
75,779 |
-53.0% |
161,373 |
|
Exchange losses |
GS |
76,996 |
25.8% |
61,224 |
-30.6% |
88,164 |
|
Net loss from disposal of investment
securities |
GT |
0 |
0% |
0 |
0% |
0 |
Extraordinary income (VII)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total extraordinary income (Total VII) |
HD |
201,174 |
728.6% |
24,278 |
-44.5% |
43,749 |
|
Extraordinary operating income |
HA |
64,760 |
758.4% |
7,544 |
0% |
0 |
|
Extraordinary income from capital
transactions |
HB |
0 |
0% |
16,734 |
-61.7% |
43,749 |
|
Released provisions and transferred charges |
HC |
136,414 |
0% |
0 |
0% |
0 |
Extraordinary charges (VIII)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total extraordinary charges (Total VIII) |
HH |
399,562 |
-43.7% |
709,942 |
266.6% |
193,650 |
|
Extraordinary operating charges |
HE |
268,554 |
35.7% |
197,836 |
2.2% |
193,509 |
|
Extraordinary charges from capital transactions |
HF |
24,523 |
-46.2% |
45,583 |
0% |
0 |
|
Extraordinary reserves and provisions |
HG |
106,485 |
-77.2% |
466,523 |
330767.4% |
141 |
Employee profit sharing (IX)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Employee profit sharing (Total IX) |
HJ |
0 |
0% |
0 |
0% |
0 |
Tax on profits (X)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Tax on profits (Total X) |
HK |
383,171 |
-34.6% |
585,633 |
387.6% |
120,112 |
References
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Of which equipment leases |
HP |
0 |
0% |
0 |
0% |
0 |
|
Of which property leases |
HQ |
0 |
0% |
0 |
0% |
0 |
|
Of which transferred charges |
A1 |
0 |
0% |
0 |
0% |
0 |
|
Of which trader's own contributions |
A2 |
0 |
0% |
0 |
0% |
0 |
|
Of which royalties on licences and patents
(income) |
A3 |
0 |
0% |
0 |
0% |
0 |
|
Of which royalties on licences and patents
(charges) |
A4 |
0 |
0% |
0 |
0% |
0 |
Other incomes tax return forms
Fixed Assets
Grand Total Fixed Assets (I to IV)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
OG |
0 |
0% |
0 |
0% |
0 |
|
Increasess due to revaluation |
OH |
0 |
0% |
0 |
0% |
0 |
|
Decreasess, acquisitions, creations,
contributions |
OJ |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by budget item transfer |
OK1 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by transfers |
OK2 |
63,088 |
-4.6% |
66,152 |
-60.2% |
166,251 |
|
Gross value at the end of period |
OL |
5,030,458 |
10.1% |
4,568,431 |
30.1% |
3,510,674 |
Research and development Charge (Total I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
CZ |
0 |
0% |
0 |
0% |
0 |
|
Increasess due to revaluation |
KB |
0 |
0% |
0 |
0% |
0 |
|
Increasess, acquisitions, creations,
contributions |
KC |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by budget item transfer |
CO1 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by transfers |
CO2 |
0 |
0% |
0 |
0% |
0 |
|
Gross value at the end of period |
DO |
0 |
0% |
0 |
0% |
0 |
Other budget item from Intangible fixed
assets (Total II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
KD |
347,111 |
-9.8% |
384,684 |
1.5% |
379,038 |
|
Increasess due to revaluation |
KE |
0 |
0% |
0 |
0% |
0 |
|
Increasess, acquisitions, creations,
contributions |
KF |
1,100 |
-86.7% |
8,292 |
46.9% |
5,646 |
|
Decreasess by budget item transfer |
LV1 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by transfers |
LV2 |
0 |
0% |
45,865 |
0% |
0 |
|
Gross value at the end of period |
LW |
348,211 |
0.3% |
347,111 |
-9.8% |
384,684 |
Tangible fixed assets (Total III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
LN |
533,227 |
11.9% |
476,329 |
9.3% |
435,936 |
|
Increasess due to revaluation |
LO |
0 |
0% |
0 |
0% |
0 |
|
Increasess, acquisitions, creations,
contributions |
LP |
13,229 |
-82.9% |
77,185 |
87.1% |
41,243 |
|
Decreasess by budget item transfer |
NG1 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by transfers |
NG2 |
63,088 |
211.0% |
20,287 |
2286.7% |
850 |
|
Gross value at the end of period |
NH |
483,368 |
-9.4% |
533,227 |
11.9% |
476,329 |
Financial assets (Total IV)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
LQ |
3,680,520 |
38.9% |
2,649,661 |
31.6% |
2,013,506 |
|
Increasess due to revaluation |
LR |
0 |
0% |
0 |
0% |
0 |
|
Increasess, acquisitions, creations,
contributions |
LS |
518,359 |
-50.1% |
1,038,431 |
29.6% |
801,556 |
|
Decreasess by budget item transfer |
NJ1 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by transfers |
NJ2 |
0 |
0% |
0 |
0% |
165,401 |
|
Gross value at the end of period |
NK |
4,198,879 |
13.8% |
3,688,092 |
39.2% |
2,649,661 |
Reserve for depreciation
Situation and movement of reserve for
depreciation - Grand total (I-II-III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Reserve for depreciation value at begin of
period |
ON |
0 |
0% |
0 |
0% |
0 |
|
Increases |
OP |
0 |
0% |
0 |
0% |
0 |
|
Decreasess |
OQ |
0 |
0% |
0 |
0% |
0 |
|
Reserve for depreciation value at the end
of period |
OR |
0 |
0% |
0 |
0% |
0 |
Research and development charge (Total I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Reserve for depreciation value at begin of
period |
CY |
0 |
0% |
0 |
0% |
0 |
|
Increases |
PB |
0 |
0% |
0 |
0% |
0 |
|
Decreasess |
PC |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by budget item transfer |
PD |
0 |
0% |
0 |
0% |
0 |
Other intangible assets (Total II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Reserve for depreciation value at begin of
period |
PE |
176,638 |
40.8% |
125,448 |
138.7% |
52,561 |
|
Increases |
PF |
171,354 |
148.6% |
68,916 |
-5.4% |
72,887 |
|
Decreasess |
PG |
0 |
0% |
17,726 |
0% |
0 |
|
Decreasess by budget item transfer |
PH |
347,992 |
97.0% |
176,638 |
40.8% |
125,448 |
Total fixed assets amotisation (Total III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Reserve for depreciation value at begin of
period |
QU |
324,071 |
23.1% |
263,189 |
33.1% |
197,798 |
|
Increases |
QV |
67,356 |
5.7% |
63,726 |
-3.8% |
66,243 |
|
Decreases |
QW |
38,565 |
1256.5% |
2,843 |
234.5% |
850 |
|
Decreasess by budget item transfer |
QX |
352,862 |
8.9% |
324,072 |
23.1% |
263,191 |
Movements during period affecting charge
allocated over several period
Deferred charges and debt issuance costs
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value at begin of period |
Z91 |
0 |
0% |
0 |
0% |
0 |
|
Increases |
Z92 |
0 |
0% |
0 |
0% |
0 |
|
Depreciation of fixed assets during period |
Z9 |
0 |
0% |
0 |
0% |
0 |
|
Decreasess by budget item transfer |
B1 |
0 |
0% |
0 |
0% |
0 |
Premium refund of obligations
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Net value at begin of period |
SP1 |
0 |
0% |
0 |
0% |
0 |
|
Increases |
SP2 |
0 |
0% |
0 |
0% |
0 |
|
Depreciation of fixed assets during period |
SP |
0 |
0% |
0 |
0% |
0 |
|
Net value at the end of period |
SR |
0 |
0% |
0 |
0% |
0 |
Provisions included in balance sheet
Grand Total (I-II-III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Value at begining of period |
7C |
2,204,793 |
6.8% |
2,065,118 |
-3.2% |
2,133,852 |
|
Increases |
UB |
61,765 |
-94.5% |
1,115,100 |
106.1% |
541,163 |
|
Decreases |
UC |
1,299,570 |
33.2% |
975,424 |
59.9% |
609,897 |
|
Value at the end of period |
UD |
966,988 |
-56.1% |
2,204,794 |
6.8% |
2,065,118 |
Includes Total allocations
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Operating |
UE |
60,680 |
-90.3% |
622,561 |
17.7% |
528,972 |
|
Financial |
UG |
1,085 |
-95.9% |
26,288 |
115.6% |
12,191 |
|
Exceptional |
UJ |
0 |
0% |
466,251 |
0% |
0 |
Includes Total Withdrawal
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Operating |
UF |
1,136,867 |
18.0% |
963,234 |
57.9% |
609,897 |
|
Financial |
UH |
26,288 |
115.7% |
12,190 |
0% |
0 |
|
Exceptional |
UK |
136,414 |
0% |
0 |
0% |
0 |
Total regulated provisions (Total I)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Value at begining of period |
3Z |
0 |
0% |
0 |
0% |
0 |
|
Increases |
TS |
0 |
0% |
0 |
0% |
0 |
|
Decreases |
TT |
0 |
0% |
0 |
0% |
0 |
|
Value at the end of period |
TU |
0 |
0% |
0 |
0% |
0 |
Total risk and charge provisions (Total II)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Value at begining of period |
5Z |
492,536 |
3940.2% |
12,191 |
0% |
0 |
|
Increases |
TV |
1,085 |
-99.8% |
492,539 |
3940.2% |
12,191 |
|
Decreases |
TW |
162,702 |
1234.6% |
12,191 |
0% |
0 |
|
Value at the end of period |
TX |
330,919 |
-32.8% |
492,539 |
3940.2% |
12,191 |
Total Provision for depreciation (Total III)
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Value at begining of period |
7B |
1,712,255 |
-16.6% |
2,052,927 |
-3.8% |
2,133,852 |
|
Increases |
TY |
60,680 |
-90.3% |
622,561 |
17.7% |
528,972 |
|
Decreases |
TZ |
1,136,867 |
18.0% |
963,234 |
57.9% |
609,897 |
|
Value at the end of period |
UA |
636,068 |
-62.9% |
1,712,254 |
-16.6% |
2,052,927 |
State deadlines claims and debts at the end
of period
State claims
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Gross value |
VT |
11,090,955 |
46.3% |
7,583,216 |
-8.8% |
8,311,222 |
|
1 year at most |
VU |
10,460,151 |
90.9% |
5,480,424 |
-24.4% |
7,246,861 |
|
More than one year |
VV |
630,804 |
-70.0% |
2,102,792 |
97.6% |
1,064,361 |
State of loans
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Claims related to holdings (gross) |
UL |
245,522 |
3.7% |
236,853 |
3.9% |
227,962 |
|
Claims related to shareholdings (1 year at
most) |
UM |
0 |
0% |
0 |
0% |
0 |
|
Loans (gross) |
UP |
2,304,335 |
26.6% |
1,819,697 |
130.3% |
790,157 |
|
Loans (1 year at most) |
UR |
1,965,975 |
0% |
0 |
0% |
0 |
|
Other financial assets (gross) |
UT |
46,922 |
1.5% |
46,242 |
0% |
46,242 |
|
Other financial assets (1 year at most) |
UV |
0 |
0% |
0 |
0% |
0 |
Receivables statement of assets
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Customers doubtful or disputed |
VA |
0 |
0% |
0 |
0% |
0 |
|
Other claims customer |
UX |
6,210,077 |
55.2% |
4,000,546 |
-31.8% |
5,867,987 |
|
Receivables represent Loaned Securities |
UU |
0 |
0% |
0 |
0% |
0 |
|
Provision for depreciation previously
established |
UQ |
0 |
0% |
0 |
0% |
0 |
|
Personnel and associated accounts |
UY |
1,195 |
0% |
0 |
0% |
0 |
|
Social Security and other social
organizations |
UZ |
0 |
0% |
0 |
0% |
0 |
|
Income taxes |
VM |
209,263 |
0% |
0 |
0% |
0 |
|
Value added tax |
VB |
1,238,718 |
133.0% |
531,746 |
7.6% |
494,296 |
|
Other taxes and payments assimilated |
VN |
80,344 |
22.9% |
65,354 |
26.1% |
51,814 |
|
State and other public - Miscellaneous |
VP |
107,208 |
48.1% |
72,403 |
-0.5% |
72,756 |
|
Group and Associates |
VC |
0 |
0% |
0 |
0% |
0 |
|
Accounts receivable (including claims
relating to the operation of pension titles) |
VR |
432,792 |
-29.8% |
616,914 |
121.9% |
277,997 |
Prepaid
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Prepaid |
VS |
214,579 |
10.9% |
193,460 |
-59.9% |
482,010 |
State Debt
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Total debt (gross) |
VY |
13,576,484 |
45.8% |
9,310,071 |
-16.8% |
11,196,262 |
|
1 year at most |
VZ2 |
13,216,078 |
50.7% |
8,769,461 |
-21.7% |
11,196,262 |
|
More than 1 year and 5 years at most |
VZ3 |
360,406 |
-33.3% |
540,610 |
0% |
0 |
|
More than 5 years |
VZ4 |
0 |
0% |
0 |
0% |
0 |
Details
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Convertible bonds (gross) |
7Y1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
7Y2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
7Y3 |
0 |
0% |
0 |
0% |
0 |
|
Other bonds (gross) |
7Z1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
7Z2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
7Z3 |
0 |
0% |
0 |
0% |
0 |
|
Borrowing & debts to 1 year maximum at
the origin (gross) |
VG1 |
2,593 |
18.3% |
2,192 |
-28.1% |
3,050 |
|
1 year at most |
VG2 |
2,593 |
18.3% |
2,192 |
-28.1% |
3,050 |
|
More than 1 year and 5 years at most |
VG3 |
0 |
0% |
0 |
0% |
0 |
|
Borrowing & debts to more than 1 year
at the origin (gross) |
VH1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
VH2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
VH3 |
0 |
0% |
0 |
0% |
0 |
|
Loans and various financial liabilities
(gross) |
8A1 |
732,401 |
-44.2% |
1,313,312 |
-10.8% |
1,471,565 |
|
1 year at most |
8A2 |
371,995 |
-51.9% |
772,702 |
-47.5% |
1,471,565 |
|
More than 1 year and 5 years at most |
8A3 |
360,406 |
-33.3% |
540,610 |
0% |
0 |
|
Suppliers and associated accounts (gross) |
8B1 |
10,092,865 |
90.6% |
5,294,008 |
-31.4% |
7,720,170 |
|
1 year at most |
8B2 |
10,092,865 |
90.6% |
5,294,008 |
-31.4% |
7,720,170 |
|
More than 1 year and 5 years at most |
8B3 |
10,092,865 |
90.6% |
5,294,008 |
-31.4% |
7,720,170 |
|
Personnel and associated accounts (gross) |
8C1 |
243,314 |
32.7% |
183,374 |
-21.0% |
232,226 |
|
1 year at most |
8C2 |
243,314 |
32.7% |
183,374 |
-21.0% |
232,226 |
|
More than 1 year and 5 years at most |
8C3 |
0 |
0% |
0 |
0% |
0 |
|
Social Security and other social
organizations (gross) |
8D1 |
173,120 |
-3.3% |
179,020 |
14.2% |
156,715 |
|
1 year at most |
8D2 |
173,120 |
-3.3% |
179,020 |
14.2% |
156,715 |
|
More than 1 year and 5 years at most |
8D3 |
0 |
0% |
0 |
0% |
0 |
|
Taxes on profits (gross) |
8E1 |
0 |
0% |
326,763 |
1336.6% |
22,746 |
|
1 year at most |
8E2 |
0 |
0% |
326,763 |
1336.6% |
22,746 |
|
More than 1 year and 5 years at most |
8E3 |
0 |
0% |
0 |
0% |
0 |
|
VAT (Gross) |
VW1 |
141,992 |
178.1% |
51,051 |
-58.4% |
122,780 |
|
1 year at most |
VW2 |
141,992 |
178.1% |
51,051 |
-58.4% |
122,780 |
|
More than 1 year and 5 years at most |
VW3 |
0 |
0% |
0 |
0% |
0 |
|
Backed Obligations (gross) |
VX1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
VX2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
VX3 |
0 |
0% |
0 |
0% |
0 |
|
Other taxes and assimilated (gross) |
VQ1 |
126,962 |
14.4% |
111,007 |
22.4% |
90,716 |
|
1 year at most |
VQ2 |
126,962 |
14.4% |
111,007 |
22.4% |
90,716 |
|
More than 1 year and 5 years at most |
VQ3 |
0 |
0% |
0 |
0% |
0 |
|
Assets and liabilities associated accounts
(gross) |
8J1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
8J2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
8J3 |
0 |
0% |
0 |
0% |
0 |
|
More than 5 years |
8J4 |
0 |
0% |
0 |
0% |
0 |
|
Groups and associates (gross) |
VI1 |
1,416,427 |
144.0% |
580,387 |
-9.1% |
638,160 |
|
1 year at most |
VI2 |
1,416,427 |
144.0% |
580,387 |
-9.1% |
638,160 |
|
More than 1 year and 5 years at most |
VI3 |
0 |
0% |
0 |
0% |
0 |
|
More than 5 years |
V14 |
0 |
0% |
0 |
0% |
0 |
|
Other liabilities (gross) |
8K1 |
18,482 |
-96.4% |
513,403 |
105.6% |
249,749 |
|
1 year at most |
8K2 |
18,482 |
-96.4% |
513,403 |
105.6% |
249,749 |
|
More than 1 year and 5 years at most |
8K3 |
0 |
0% |
0 |
0% |
0 |
|
Debt representative of borrowed securities
(gross) |
SZ1 |
0 |
0% |
0 |
0% |
0 |
|
1 year at most |
SZ2 |
0 |
0% |
0 |
0% |
0 |
|
More than 1 year and 5 years at most |
SZ3 |
0 |
0% |
0 |
0% |
0 |
|
Products in advance (gross) |
8L1 |
628,327 |
-16.8% |
755,554 |
54.7% |
488,384 |
|
1 year at most |
8L2 |
628,327 |
-16.8% |
755,554 |
54.7% |
488,384 |
|
More than 1 year and 5 years at most |
8L3 |
0 |
0% |
0 |
0% |
0 |
References
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Loans made during the period |
VJ |
540,610 |
0% |
0 |
0% |
0 |
|
Debt repaid during the period |
VK |
0 |
0% |
0 |
0% |
0 |
Table allocation results and other
information
Dividends distributed
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Dividends |
ZE |
0 |
0% |
0 |
0% |
0 |
Commitments
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Commitments leasing furniture |
YQ |
0 |
0% |
0 |
0% |
0 |
|
Commitments Real Estate Leasing |
YR |
0 |
0% |
0 |
0% |
0 |
|
Effects brought to the discount and
unmatured |
YS |
0 |
0% |
0 |
0% |
0 |
Other charges Externes
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Subcontracting |
YT |
0 |
0% |
0 |
0% |
0 |
|
Rentals, rental charges and condominiums |
XQ |
0 |
0% |
0 |
0% |
0 |
|
Staff outside the company |
YU |
0 |
0% |
0 |
0% |
0 |
|
Remuneration intermediaries and fees
(excluding fees) |
SS |
0 |
0% |
0 |
0% |
0 |
|
Fees, commissions and brokerage |
YV |
0 |
0% |
0 |
0% |
0 |
|
Other accounts |
ST |
0 |
0% |
0 |
0% |
0 |
|
Total Other purchases and external |
ZJ |
0 |
0% |
0 |
0% |
0 |
Taxes and Fees
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Business tax |
YW |
0 |
0% |
0 |
0% |
0 |
|
Other taxes and payments assimilated |
9Z |
0 |
0% |
0 |
0% |
0 |
|
Total taxes and fees |
YX |
0 |
0% |
0 |
0% |
0 |
VAT
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Amount VAT collected |
YY |
0 |
0% |
0 |
0% |
0 |
|
Total VAT on goods and services |
YZ |
0 |
0% |
0 |
0% |
0 |
Average number of employees
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Average number of employees |
YP |
0 |
0% |
0 |
0% |
0 |
Groups and Shareholders
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
||
|
Groups and Shareholders |
ZR |
0 |
- |
- |
- |
- |
Ratios
Synthetic financial performance indicators
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|||||||||||||||||
|
Score |
Situation |
Score |
Situation |
Score |
Situation |
||||||||||||||
|
HideAFDCC 2 |
1.35 |
Fragility |
4.11 |
Healthy |
1.35 |
Fragility |
|||||||||||||
|
Description |
|
||||||||||||||||||
|
HideConan & Holder |
-0.06 |
90% |
0.09 |
40% |
0.00 |
70% |
|||||||||||||
|
Description |
|
||||||||||||||||||
|
HideAltman |
2.99 |
Warning signs |
3.72 |
Good shape |
2.71 |
Warning signs |
|||||||||||||
|
Description |
|
||||||||||||||||||
Structure and Liquidity
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Fixed Asset Financing |
2.33 |
1.7% |
2.29 |
-13.9% |
2.66 |
2.77 |
-15.9% |
|
Global Debt |
151 days |
37.3% |
110 days |
-30.8% |
159 days |
115 days |
31.3% |
|
Working Capital Fund overall net |
75 days |
7.1% |
70 days |
-15.7% |
83 days |
68 days |
10.3% |
|
Financial independence |
378.60 % |
2.0% |
371.24 % |
25.5% |
295.81 % |
214.73 % |
76.3% |
|
Solvability |
36.78 % |
-11.9% |
41.77 % |
16.9% |
35.72 % |
35.68 % |
3.1% |
|
Capacity debt futures |
314,122.52 % |
-2.2% |
321,086.86 % |
56.7% |
204,914.72 % |
1,715.91 % |
18206.5% |
|
Coverage of current assets by net working
capital overall |
36.70 % |
-11.1% |
41.26 % |
14.6% |
36.01 % |
43.43 % |
-15.5% |
|
General Liquidity |
0.79 |
27.4% |
0.62 |
-4.6% |
0.65 |
0.76 |
3.9% |
|
Restricted Liquidity |
0.91 |
13.8% |
0.80 |
11.1% |
0.72 |
1.16 |
-21.6% |
Management or rotation
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Need background in operating working
capital |
62 days |
5.1% |
59 days |
-16.9% |
71 days |
26 days |
138.5% |
|
Treasury |
18 days |
0% |
18 days |
50.0% |
12 days |
15 days |
20.0% |
|
Inventory turnover of goods |
0 days |
0% |
0 days |
- |
- |
58 days |
0% |
|
Average length of credit granted to
customers |
69 days |
46.8% |
47 days |
-43.4% |
83 days |
59 days |
16.9% |
|
Average length of credit obtained suppliers |
116 days |
70.6% |
68 days |
-46.0% |
126 days |
62 days |
87.1% |
|
Inventory turnover of raw materials in
industrial enterprises |
135 days |
-13.5% |
156 days |
-12.4% |
178 days |
0 days |
0% |
|
Inventory turnover of intermediate and
finished products in the industrial enterprise |
6,689 days |
17.0% |
5,716 days |
7.2% |
5,334 days |
1,695 days |
294.6% |
|
Rotation tangible assets |
6,688.70 % |
17.0% |
5,716.38 % |
7.2% |
5,334.49 % |
2,036.07 % |
228.5% |
Profitability of the business
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Margin trading |
0.38 % |
65.2% |
0.23 % |
0% |
0.00 % |
29.81 % |
-98.7% |
|
Profitability of the business |
-2.48 % |
-187.3% |
2.84 % |
536.9% |
-0.65 % |
4.01 % |
-161.8% |
|
Net profit |
7.15 % |
9.5% |
6.53 % |
-4.9% |
6.87 % |
2.23 % |
220.6% |
|
Growth rate of turnover (excluding VAT) |
6.07 % |
-69.6% |
19.96 % |
-29.2% |
28.19 % |
1.95 % |
211.3% |
|
Rates integration |
3.56 % |
-60.0% |
8.91 % |
30.8% |
6.81 % |
24.04 % |
-85.2% |
|
Rate leasing furniture |
0.00 % |
0% |
0.00 % |
0% |
0.00 % |
0.00 % |
0% |
|
Work Factor |
153.98 % |
148.4% |
61.99 % |
-36.9% |
98.24 % |
66.91 % |
130.1% |
|
Weight interests |
0.51 % |
-5.6% |
0.54 % |
-47.6% |
1.03 % |
0.19 % |
168.4% |
Return on capital
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||
|
Cash flow from the overall profitability |
3.94 % |
-28.1% |
5.48 % |
-4.0% |
5.71 % |
3.13 % |
25.9% |
|
Rates of economic profitability |
-8.00 % |
-180.0% |
10.00 % |
600.0% |
-2.00 % |
16.00 % |
-150.0% |
|
Financial profitability |
8,145,197.00 % |
15.7% |
7,038,224.00 % |
12.6% |
6,249,899.00 % |
119,799.00 % |
6699.1% |
|
Return on investment |
24.03 % |
-0.4% |
24.12 % |
0.5% |
24.01 % |
11.78 % |
104.0% |
Management intermediate balances
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||||||||
|
Turnover |
32,331,040 |
6.1% |
30,481,271 |
20.0% |
25,409,737 |
730,649 |
4325.0% |
|||||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||||||||
|
Sales of goods |
653,387 |
231.5% |
197,083 |
0% |
0 |
- |
||||||||||
|
- Purchase of goods |
529,424 |
313.1% |
128,169 |
0% |
0 |
- |
||||||||||
|
+/- Stock of goods variation |
0 |
0% |
0 |
0% |
0 |
- |
||||||||||
|
Trading margin |
123,963 € |
79.9% |
68,914 € |
0% |
0 € |
163,158 € |
-24.0% |
|||||||||
|
0.38 % CA |
65.2% |
0.23 % CA |
0% |
0.00 % CA |
30.42 % CA |
-98.8% |
||||||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||||||||||||
|
Sale of goods produced |
31,677,653 |
4.6% |
30,284,188 |
19.2% |
25,409,737 |
- |
|||||||||||
|
+/- Stocked production |
91,517 |
-74.6% |
360,077 |
122.3% |
-1,617,659 |
- |
|||||||||||
|
+ Self-constructed assets |
0 |
0% |
0 |
0% |
0 |
- |
|||||||||||
|
Period production |
31,769,170 € |
3.7% |
30,644,265 € |
28.8% |
23,792,078 € |
48,657 € |
65192.8% |
||||||||||
|
98.26 % CA |
-2.3% |
100.53 % CA |
7.4% |
93.63 % CA |
6.14 % CA |
1500.3% |
|||||||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||||||||||||
|
Trading margin |
123,963 |
79.9% |
68,914 |
0% |
0 |
163,158 |
-24.0% |
||||||||||
|
+ Period Production |
31,769,170 |
3.7% |
30,644,265 |
28.8% |
23,792,078 |
48,657 |
65192.8% |
||||||||||
|
- Purchase of raw materials |
12,786,967 |
31.8% |
9,704,018 |
-11.8% |
11,008,035 |
- |
|||||||||||
|
+/- Change in stocks of raw materiels |
-786,002 |
-164.7% |
1,215,323 |
162.7% |
-1,936,860 |
- |
|||||||||||
|
- Other external purchases and charges |
18,741,654 |
9.8% |
17,076,676 |
31.5% |
12,990,678 |
- |
|||||||||||
|
Added value |
1,150,514 € |
-57.7% |
2,717,162 € |
57.0% |
1,730,225 € |
180,143 € |
538.7% |
||||||||||
|
3.56 % CA |
-60.0% |
8.91 % CA |
30.8% |
6.81 % CA |
24.04 % CA |
-85.2% |
|||||||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||
|
Added value |
1,150,514 € |
-57.7% |
2,717,162 € |
57.0% |
1,730,225 € |
180,143 € |
538.7% |
|||
|
+ Operating grants |
0 |
0% |
0 |
0% |
0 |
- |
||||
|
- Tax, duty and similar payments |
180,388 |
8.8% |
165,805 |
-14.8% |
194,626 |
- |
||||
|
- Personal charges |
1,771,611 |
5.2% |
1,684,360 |
-0.9% |
1,699,791 |
- |
||||
|
Gross operating surplus |
-801,485 € |
-192.4% |
866,997 € |
628.0% |
-164,192 € |
24,038 € |
-3434.2% |
|||
|
-2.48 % CA |
-187.3% |
2.84 % CA |
536.9% |
-0.65 % CA |
4.01 % CA |
-161.8% |
||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||
|
Gross operating surplus |
-801,485 € |
-192.4% |
866,997 € |
628.0% |
-164,192 € |
24,038 € |
-3434.2% |
|||
|
+ Release of reserves and provisions |
1,195,056 |
24.0% |
963,683 |
56.3% |
616,367 |
- |
||||
|
+ Other operating income |
2,699,263 |
22.0% |
2,213,227 |
-8.2% |
2,411,365 |
- |
||||
|
- Depreciation/ Amortisation |
192,908 |
-74.4% |
754,929 |
13.0% |
667,961 |
- |
||||
|
- Other charges |
2,128 |
542.9% |
331 |
619.6% |
46 |
- |
||||
|
Operating result |
2,897,798 € |
-11.9% |
3,288,647 € |
49.8% |
2,195,533 € |
20,118 € |
14304.0% |
|||
|
8.96 % CA |
-17.0% |
10.79 % CA |
24.9% |
8.64 % CA |
3.13 % CA |
186.3% |
||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||||
|
Operating result |
2,897,798 € |
-11.9% |
3,288,647 € |
49.8% |
2,195,533 € |
20,118 € |
14304.0% |
|||||
|
+/- Result of joint-venture transferred
from/to other partners |
0 |
0% |
0 |
0% |
0 |
- |
||||||
|
+ Financial income |
158,172 |
15.1% |
137,467 |
66.3% |
82,670 |
- |
||||||
|
- Financial charges |
164,241 |
0.6% |
163,291 |
-37.6% |
261,728 |
- |
||||||
|
Pre-tax result |
2,891,729 € |
-11.4% |
3,262,823 € |
61.8% |
2,016,475 € |
19,073 € |
15061.8% |
|||||
|
8.94 % CA |
-16.4% |
10.70 % CA |
34.8% |
7.94 % CA |
2.92 % CA |
206.2% |
||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
|||||||
|
Extraordinary income |
201,174 |
728.6% |
24,278 |
-44.5% |
43,749 |
38 |
529305.3% |
|||||
|
- Extraordinary charges |
399,562 |
-43.7% |
709,942 |
266.6% |
193,650 |
- |
||||||
|
Extraordinary result |
-198,388 € |
71.1% |
-685,664 € |
-357.4% |
-149,901 € |
0 € |
0% |
|||||
|
-0.61 % CA |
72.9% |
-2.25 % CA |
-281.4% |
-0.59 % CA |
0.00 % CA |
0% |
||||||
|
30/09/2012 |
Variation |
30/09/2011 |
Variation |
30/09/2010 |
SECTOR MEDIAN 2012 |
||||
|
Pre-tax result |
2,891,729 € |
-11.4% |
3,262,823 € |
61.8% |
2,016,475 € |
19,073 € |
15061.8% |
||
|
Extraordinary result |
-198,388 € |
71.1% |
-685,664 € |
-357.4% |
-149,901 € |
0 € |
0% |
||
|
- Employee profit sharing |
0 |
0% |
0 |
0% |
0 |
- |
|||
|
- Tax on profits |
383,171 |
-34.6% |
585,633 |
387.6% |
120,112 |
- |
|||
|
Net result |
2,310,170 € |
16.0% |
1,991,526 € |
14.0% |
1,746,462 € |
16,729 € |
13709.8% |
||
|
7.15 % CA |
9.5% |
6.53 % CA |
-4.9% |
6.87 % CA |
2.23 % CA |
220.6% |
|||
Key Performance Indicators
Find below a comparison of the company based on
the industry code (primary) with other companies from the same industry. The
following analysis has been based on the industry code 4646Z - Wholesale
(intercompany trade) of pharmaceutical goods.
Graphical analysis
Net Turnover Company Result Sector Average30/09/201230/09/201130/09/20100M10M20M30M40M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
32,331,040 € |
30,481,271 € |
25,409,737 € |
|
Sector Average |
29,931,363 € |
29,929,064 € |
28,934,655 € |
Net Profit Company Result Sector Average30/09/201230/09/201130/09/20100M1M2M3M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
2,310,173 € |
1,991,525 € |
1,746,462 € |
|
Sector Average |
662,885 € |
628,490 € |
605,870 € |
Net Export Turnover Company Result Sector Average30/09/201230/09/201130/09/20100M1M2M3M4M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
2,192,408 € |
1,774,662 € |
2,559,699 € |
|
Sector Average |
2,856,159 € |
2,647,946 € |
2,858,065 € |
Account Total Company Result Sector Average30/09/201230/09/201130/09/20100M10M20M30M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
22,144,859 € |
16,849,700 € |
17,495,908 € |
|
Sector Average |
14,032,882 € |
14,387,297 € |
13,524,616 € |
Shareholders Equity Company Result Sector
Average30/09/201230/09/201130/09/20100M2.5M5M7.5M10M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
8,145,197 € |
7,038,224 € |
6,249,899 € |
|
Sector Average |
4,553,275 € |
4,551,179 € |
4,458,481 € |
Liabilities Company Result Sector
Average30/09/201230/09/201130/09/20100M5M10M15M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
13,576,484 € |
9,310,071 € |
11,196,262 € |
|
Sector Average |
8,322,300 € |
8,610,584 € |
7,943,653 € |
Need background in operating working capital
Company Result Sector Average30/09/201230/09/201130/09/2010-100-50050100
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
62 € |
59 € |
71 € |
|
Sector Average |
-68 € |
83 € |
9 € |
Gross operating surplus (EBE) Company Result
Sector Average30/09/201230/09/201130/09/2010-1M0M1M2M
|
30/09/2012 |
30/09/2011 |
30/09/2010 |
|
|
Company Result |
-801,485 € |
866,997 € |
-164,192 € |
|
Sector Average |
891,615 € |
1,039,659 € |
1,118,450 € |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 64.03 |
|
|
1 |
INR 90.40 |
|
Euro |
1 |
INR 79.73 |
|
Euro |
1 |
INR 79.85 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
VAR |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.